Innate Immune Cells and Early Fibrotic Repair After a Heart Attack
Official title: Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction
Run by Shanghai 10th People's Hospital · NCT07764588 · Data updated 2026-11-12
This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Shanghai 10th People's Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 14, 2026 |
| Trial ID | NCT07764588 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with acute STEMI planned for PPCI within 12 hours of symptom onset.
✕Probably not a fit
Patients who do not have STEMI or who cannot undergo MRI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this observational study, 50 adults with STEMI undergoing PPCI will have blood samples analyzed for neutrophil and monocyte phenotypes, plus serum cytokines. Neutrophils will be sorted for transcriptome sequencing to explore gene expression patterns. At about one week after admission, participants will undergo cardiac MRI to measure the myocardial salvage index, LGE area, microvascular obstruction, extracellular volume, and LVEF to relate immune profiles to early fibrotic repair.
Why it matters
Potential benefit: If patterns are identified, this could help predict which patients are likelier to experience certain fibrotic responses after a heart attack.
How similar studies have gone: Previous work has shown associations between immune cell states and tissue repair in cardiovascular injury; this study builds on that by linking specific phenotypes to MRI-derived fibrosis metrics.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \---- Age \> 18 and ≤ 80 years old \- Patients with acute STEMI within 12 hours of symptom onset who are planned to receive PPCI Exclusion Criteria: * Prior revascularization * Known allergy to gadopentetate dimeglumine contrast agent * Pregnancy or planned pregnancy within the next 6 months * Life expectancy \< 1 year * Metallic implants or claustrophobia that precluded MRI * Severe COPD or inability to hold breath for MRI * Severe hepatic or renal dysfunction (ALT \> 5×ULN or eGFR \< 15 mL/min/1.73 m²)
Where it's running
-
Shanghai Tenth People's Hospital
Shanghai, China Recruiting
Study contacts
- Study coordinator: Jianhui Zhuang, MD
- Email: jh_zhuang@tongji.edu.cn
- Phone: 86-13621742833
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Digital cardiac rehab to help heart attack patients improve function
A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
Remote Balance in Everyday Life for young MI patients with distress
This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.
-
See if virtual reality can help MI patients in ICU feel less anxious and have steadier vital signs
A VR glasses intervention is tested in conscious MI patients in the ICU to see if it changes their vital signs and anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.